In vivo inhibition of p38 MAPK attenuates angiotensin II-induced superoxide anion production and target organ damage through suppression of NAD(P)H oxidase

被引：0
|
作者：
Bao, Weike [1 ]
Behm, David J. [1 ]
Nerurkar, Sandhya S. [1 ]
Ao, Zhaohui [1 ]
Bentley, Ross [1 ]
Mirabile, Rosanna C. [1 ]
Johns, Douglas G. [1 ]
Woods, Tina N. [1 ]
Doe, Christopher P. [1 ]
Coatney, Robert W. [1 ]
Ohlstein, Jason F. [1 ]
Douglas, Stephen A. [1 ]
Yue, Tian-Li [1 ]
Willette, Robert N. [1 ]
机构：
[1] GlaxoSmithKline Inc, King Of Prussia, PA USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
867
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [1] Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production
    Bao, Weike
    Behm, David J.
    Nerurkar, Sandhya S.
    Ao, Zhaohui
    Bentley, Ross
    Mirabile, Rosanna C.
    Johns, Douglas G.
    Woods, Tina N.
    Doe, Christopher P. A.
    Coatney, Robert W.
    Ohlstein, Jason F.
    Douglas, Stephen A.
    Willette, Robert N.
    Yue, Tian-Li
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (06) : 362 - 368
  • [2] p38 Mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage
    Park, Joon-Keun
    Fischer, Robert
    Dechend, Ralf
    Shagdarsuren, Erdenechimeg
    Gapeljuk, Andrej
    Wellner, Maren
    Meiners, Silke
    Gratze, Petra
    Al-Saadi, Nidal
    Feldt, Sandra
    Fiebeler, Anette
    Madwed, Jeffrey B.
    Schirdewan, Alexander
    Haller, Hermann
    Luft, Friedrich C.
    Muller, Dominik N.
    HYPERTENSION, 2007, 49 (03) : 481 - 489
  • [3] Does NAD(P)H oxidase-dependent superoxide production mediate angiotensin (Ang) II-induced vasoconstriction?
    Tom, B
    Schuijt, MP
    de Vries, R
    Saxena, PR
    Danser, AHJ
    HYPERTENSION, 2002, 40 (04) : 579 - 579
  • [4] Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway
    Yang, Chuanxi
    Wu, Xiaoguang
    Shen, Yihui
    Liu, Chi
    Kong, Xiangqing
    Li, Peng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
  • [5] NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II
    Sun, CW
    Sellers, KW
    Sumners, C
    Raizada, MK
    CIRCULATION RESEARCH, 2005, 96 (06) : 659 - 666
  • [6] Angiotensin II-induced elevation of arginase activity and impaired vasorelaxation can be prevented by p38 MAPK inhibition
    Shatanawi, Alia
    Caldwell, Ruth B.
    Caldwell, R. William
    FASEB JOURNAL, 2011, 25
  • [7] p38 MAPK inhibition prevents angiotensin II-induced elevation of arginase (ARG) activity and impaired vasorelaxation
    Shatanawi, Alia
    Romero, M. J.
    Chandra, S.
    Yao, L.
    Toque, H. Flores
    Iddings, J. A.
    Caldwell, R. B.
    Caldwell, R. W.
    FASEB JOURNAL, 2010, 24
  • [8] p38 map kinase inhibition ameliorates cardiac damage without affecting albuminuria in angiotensin (Ang) II-induced end organ damage
    Mueller, Dominik N.
    Park, Joon-Keun
    Dechend, Ralf
    Fischer, Robert
    Shagdarsuren, Erdenechimeg
    Gapeljuk, Andrej
    Wellner, Maren
    Schirdewan, Alexander
    Gratze, Petra
    Al-Saadi, Nidal
    Feldt, Sandra
    Fiebeler, Anette
    Madwed, Jeffrey B.
    Haller, Hermann
    Luft, Friedrich C.
    JOURNAL OF HYPERTENSION, 2006, 24 : 108 - 108
  • [9] Perivascular delivery of an NAD(P)H oxidase inhibitor attenuates angiotensin II-induced mouse carotid hypertrophy.
    Liu, JH
    Pagano, P
    HYPERTENSION, 2004, 43 (06) : 1350 - 1351
  • [10] Carnosol attenuates angiotensin II-induced cardiac remodeling and inflammation via directly binding to p38 and inhibiting p38 activation
    Xu, Diyun
    Ye, Bozhi
    Lin, Liming
    Jin, Yanhong
    Jiang, Yuchen
    Zheng, Zhaozheng
    Chen, Yanghao
    Han, Xue
    Wang, Wei
    Wu, Gaojun
    Zhuang, Zaishou
    Shan, Peiren
    Liang, Guang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
12345